American Oriental Bioengineering
Bioengineering firm expects record revenue growth, income for 2003
Published in Healthcare Mergers, Acquisitions and Ventures Week, April 10th, 2004
AOBO reported net revenues of $1.12 million for the full year 2002, with a net profit of $0.11 per share. The company posted a 92% jump in revenues to $14.8 million for the first 9 months of 2003, with net income for the first 9 months surging 320% to $3.7 million, or $0.13 per share, as compared to the same period for the prior fiscal year.
AOBO expects to release results for the fourth quarter and full year 2003, and expects to file its 10K with the Securities and Exchange Commission by the end of March 2004.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Psychiatric Solutions, Inc.
Psychiatric Solutions reports 181% fourth quarter revenue increase - AVI BioPharma, Inc.
Neugene maker reports quarterly loss of $0.10 per share - Alfacell Corporation
Savadelis named chief financial officer at pharmaceutical firm - Allos Therapeutics, Inc.
Oncology company files shelf registration statement - Alnylam Pharmaceuticals, Inc.
Isis Pharmaceuticals enters RNAi alliance - Aspreva Pharmaceuticals Corp.
Autoimmune disease drug maker completes raises $57 million - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
